About 7 results found for searched term "55-06-1" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2254 | Gatifloxacin | Antibiotic |
| Gatiflo; AM-1155; BMS-206584; PD135432 | ||
| Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family. | ||
| M2815 | Liothyronine Sodium | Thyroid Hormone Receptor |
| T3 Sodium salt; Sodium L-3,3',5-triiodothyronine; Liothyronine sodium | ||
| Liothyronine Sodium is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis. Liothyronine sodium is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively. | ||
| M17826 | Sericic acid | Triterpenoids |
| Sericic acid | ||
| M19867 | Gatifloxacin hydrochloride | Topoisomerase |
| AM-1155 hydrochloride; CG5501 hydrochloride; BMS-206584 hydrochloride; PD135432 hydrochloride | ||
| Gatifloxacin (AM-1155, CG5501, BMS-206584, PD135432) hydrochloride is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases with IC50 of 13.8 μg/ml and 0.109 μg/ml for S. aureus topoisomerase IV and E. coli DNA gyrase, respectively. | ||
| M20392 | Bimatoprost | Prostaglandin Receptor |
| Bimatoprost is a synthetic prostaglandin analog as well as a prostaglandin F (FP) receptor agonist (FPA) with IOP-lowering activity for studies related to glaucoma and IOP. | ||
| M28883 | Gatifloxacin sesquihydrate | Antibiotic |
| AM-1155 sesquihydrate; BMS-206584 sesquihydrate; PD135432 sesquihydrate | ||
| Gatifloxacin sesquihydrate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin sesquihydrate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml). | ||
| M29902 | Gatifloxacin mesylate | Antibiotic |
| AM-1155 mesylate; BMS-206584 mesylate; PD135432 mesylate | ||
| Gatifloxacin mesylate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin mesylate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
